[1]
“First ‘Real-World’ Insights on Apremilast Treatment for Patients with Plaque Psoriasis from the LAPIS-PSO Study: An Interim Analysis”, J of Skin, vol. 1, no. 3.1, p. s15, Oct. 2017, doi: 10.25251/skin.1.supp.14.